These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
455 related articles for article (PubMed ID: 19642802)
1. Clinical and epidemiological features of visceral leishmaniasis and HIV co-infection in fifteen patients from Brazil. Daher EF; Fonseca PP; Gerhard ES; Leitão TM; Silva Júnior GB J Parasitol; 2009 Jun; 95(3):652-5. PubMed ID: 19642802 [TBL] [Abstract][Full Text] [Related]
2. Visceral leishmaniasis in HIV-1-infected individuals: a common opportunistic infection in Spain? Medrano FJ; Hernández-Quero J; Jiménez E; Pineda JA; Rivero A; Sánchez-Quijano A; Velez ID; Viciana P; Castillo R; Reyes MJ AIDS; 1992 Dec; 6(12):1499-503. PubMed ID: 1362880 [TBL] [Abstract][Full Text] [Related]
3. Parasite susceptibility to amphotericin B in failures of treatment for visceral leishmaniasis in patients coinfected with HIV type 1 and Leishmania infantum. Lachaud L; Bourgeois N; Plourde M; Leprohon P; Bastien P; Ouellette M Clin Infect Dis; 2009 Jan; 48(2):e16-22. PubMed ID: 19093811 [TBL] [Abstract][Full Text] [Related]
4. Concordant HIV infection and visceral leishmaniasis in Ethiopia: the influence of antiretroviral treatment and other factors on outcome. ter Horst R; Collin SM; Ritmeijer K; Bogale A; Davidson RN Clin Infect Dis; 2008 Jun; 46(11):1702-9. PubMed ID: 18419422 [TBL] [Abstract][Full Text] [Related]
5. HIV/AIDS-associated visceral leishmaniasis in patients from an endemic area in Central-west Brazil. Alexandrino-de-Oliveira P; Santos-Oliveira JR; Dorval ME; Da-Costa Fd; Pereira GR; da Cunha RV; Paniago AM; Da-Cruz AM Mem Inst Oswaldo Cruz; 2010 Aug; 105(5):692-7. PubMed ID: 20835619 [TBL] [Abstract][Full Text] [Related]
6. Leishmaniases and HIV/AIDS co-infections: review of common features and management experiences. Ali A Ethiop Med J; 2002 Apr; 40 Suppl 1():37-49. PubMed ID: 12802830 [TBL] [Abstract][Full Text] [Related]
7. [Visceral leishmaniasis in patients with HIV infection]. Ribera E; Cucurull E; Ocaña I; Vallespí T; Gasser I; Juste C Enferm Infecc Microbiol Clin; 1995 Feb; 13(2):73-9. PubMed ID: 7711130 [TBL] [Abstract][Full Text] [Related]
8. Amphotericin B lipid complex versus meglumine antimoniate in the treatment of visceral leishmaniasis in patients infected with HIV: a randomized pilot study. Laguna F; Videla S; Jiménez-Mejías ME; Sirera G; Torre-Cisneros J; Ribera E; Prados D; Clotet B; Sust M; López-Vélez R; Alvar J; J Antimicrob Chemother; 2003 Sep; 52(3):464-8. PubMed ID: 12888588 [TBL] [Abstract][Full Text] [Related]
9. AA-amyloidosis caused by visceral leishmaniasis in a human immunodeficiency virus-infected patient. de Vallière S; Mary C; Joneberg JE; Rotman S; Bullani R; Greub G; Gillmore JD; Buffet PA; Tarr PE Am J Trop Med Hyg; 2009 Aug; 81(2):209-12. PubMed ID: 19635871 [TBL] [Abstract][Full Text] [Related]
10. [Association of acute lymphoblastic leukaemia and visceral leishmaniasis]. Nafil H; Tazi I; Mahmal L Ann Biol Clin (Paris); 2011; 69(6):729-31. PubMed ID: 22123576 [TBL] [Abstract][Full Text] [Related]
11. [The clinical and evolutional characteristics of visceral leishmaniasis in patients with HIV infection]. Delgado Fernández M; García Ordoñez MA; Martos Pérez F; Reguera Iglesias JM; Jiménez Oñate F; Colmenero Castillo JD An Med Interna; 1997 Oct; 14(10):506-10. PubMed ID: 9424140 [TBL] [Abstract][Full Text] [Related]
12. Clinical characteristics and treatment outcome of patients with visceral leishmaniasis and HIV co-infection in northwest Ethiopia. Hurissa Z; Gebre-Silassie S; Hailu W; Tefera T; Lalloo DG; Cuevas LE; Hailu A Trop Med Int Health; 2010 Jul; 15(7):848-55. PubMed ID: 20487426 [TBL] [Abstract][Full Text] [Related]
13. [Visceral leishmaniasis and HIV infection in the HAART era]. Marques N; Cabral S; Sá R; Coelho F; Oliveira J; Saraiva da Cunha JG; Meliço Silvestre A Acta Med Port; 2007; 20(4):291-8. PubMed ID: 18198072 [TBL] [Abstract][Full Text] [Related]
14. Pediatric visceral leishmaniasis in Western Sicily, Italy: a retrospective analysis of 111 cases. Cascio A; Colomba C; Antinori S; Orobello M; Paterson D; Titone L Eur J Clin Microbiol Infect Dis; 2002 Apr; 21(4):277-82. PubMed ID: 12072938 [TBL] [Abstract][Full Text] [Related]
15. [Visceral leishmaniasis: a comparative study of patients with and without human immunodeficiency virus infection]. Reus S; Sánchez R; Portilla J; Boix V; Priego M; Merino E; Román F Enferm Infecc Microbiol Clin; 1999 Dec; 17(10):515-20. PubMed ID: 10650648 [TBL] [Abstract][Full Text] [Related]
16. Liposomal amphotericin B for visceral leishmaniasis in human immunodeficiency virus-coinfected patients: 2-year treatment outcomes in Bihar, India. Sinha PK; van Griensven J; Pandey K; Kumar N; Verma N; Mahajan R; Kumar P; Kumar R; Das P; Mitra G; Flevaud L; Ferreyra C; Remartinez D; Pece M; Palma PP Clin Infect Dis; 2011 Oct; 53(7):e91-8. PubMed ID: 21890763 [TBL] [Abstract][Full Text] [Related]
17. HIV/AIDS-related visceral leishmaniasis: a clinical and epidemiological description of visceral leishmaniasis in northern Brazil. Albuquerque LC; Mendonça IR; Cardoso PN; Baldaçara LR; Borges MR; Borges Jda C; Pranchevicius MC Rev Soc Bras Med Trop; 2014; 47(1):38-46. PubMed ID: 24603735 [TBL] [Abstract][Full Text] [Related]